Juncosamine (DMBMPP)

The most selective agonist for the human 5-HT2A receptor

What is DMBMPP?

• DMBMPP (also known as juncosamine; chemical name: 2-(2,5-dimethoxy-4-bromobenzyl)-6-(2-methoxy­phenyl) piperidine) is a synthetic compound. Wikipedia+2aobious.com+2

• It belongs to a class of molecules derived from phenethylamines (specifically NBOMe-type derivatives) but incorporates a piperidine ring, making the molecule more rigid. Wikipedia+1

• First described in the literature by a team including David E. Nichols (Purdue University) in ~2011. Wikipedia+1

Main functionality / pharmacology

• DMBMPP is highly selective for the human serotonin receptor subtype 5‑HT₂A receptor (a G-protein-coupled receptor) and acts as an agonist at that receptor. Wikipedia+2PMC+2

• The selectivity: The (S,S) isomer of DMBMPP has a Kₙᵢ (binding affinity) of ~2.5 nM at the human 5-HT₂A receptor, and ~124-fold selectivity over the similar 5-HT₂C receptor subtype. Wikipedia+1

• Because 5-HT₂A is the receptor subtype most associated with classical psychedelic effects, DMBMPP is considered to have hallucinogen-like potential (based on animal models) albeit it is primarily a research tool compound. Wikipedia+1

• Additional research suggests DMBMPP may also influence microtubule polymerization (i.e., cytoskeletal dynamics) in vitro, indicating possible off-target actions or broader cell-biological effects. Nature

Use / research context

• DMBMPP is not primarily a therapeutic drug; rather it is used in research settings as a “tool compound” for studying 5-HT₂A receptor pharmacology because of its unusually high selectivity. PMC+1

• One of the reasons for its limited wider use is that its chemical synthesis is relatively difficult / inaccessible, which limits its adoption as a widespread pharmacological agent. Wikipedia

Key limitations & caveats

• Because it is so potent and selective, caution is needed in interpreting results: high selectivity does not always mean safe or predictable in vivo effects.

• Human data are extremely limited or non-existent (at least that is publicly available) — so its effects in humans, its safe dosage, toxicity profile etc., are largely unknown.

• The research suggests the possibility of microtubule / cytoskeleton interactions, which complicates the “pure receptor agonist” picture. Nature

• Any compound with strong 5-HT₂A agonist activity has the potential for psychoactive/hallucinogenic effects, which brings regulatory and safety issues.

Summary

In short:
DMBMPP is a synthetic, highly selective agonist for the serotonin 5-HT₂A receptor, used in research to probe serotonin receptor function and related pharmacology. Its rigidity and design enable it to achieve one of the highest selectivities known for that receptor subtype. It is not a mainstream therapeutic drug and is mostly of interest in neuropharmacology / receptor biology / psychedelic-mechanism studies.